IGF-1 stimulates most steps of cancer progression by signaling through the IGF-1 receptor (IGF-1R) [6,7,8], and IGF-2 promotes tumor growth through binding primarily to the insulin receptor subtype A (IR-A). The gene discussed is IGF1R; the disease is cancer.